Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 2.25 gram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 2.25 gram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 1.5 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 1.5 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 1.5 gram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 2 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 2 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 2 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 2 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 3 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 3 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 20 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 900 milligram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 3 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 3 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Anhydrous glucose |
Inferred relationship |
Some |
3 |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
1 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Anhydrous glucose |
Inferred relationship |
Some |
2 |